According to a new report published by Allied Market Research, titled, “Transrectal Ultrasound Market," The transrectal ultrasound market size was valued at $207.54 million in 2021, and is estimated to reach $313.8 million by 2031, growing at a CAGR of 4.2% from 2022 to 2031.

Transrectal ultrasound device, which was first developed in the 1970s, assists physicians to image prostate gland of patient’s body to diagnose disease and help surgeons with guiding movement of surgical instrument while performing surgeries. The biopsy is taken with guidance of transrectal ultrasound.

Transrectal ultrasound is a 10-15 minutes procedure that uses sound waves to create a video image of the prostate gland. A transducer is placed into the rectum which releases sound waves, and create echoes as they enter the prostate. Further these echoes bounce back to a computer system which translate the pattern of echoes into a picture of prostate. It provides real-time information and is highly efficient clinical modality over other modalities.

Factor that drive the growth of the global transrectal ultrasound market size include technological advancement in transrectal ultrasound systems and availability of advanced medical facilities in developed countries such as U.S., Canada, and Germany. In addition, rise in incidences of prostate cancer globally is the key factor boosting the growth of the market. For instance, according to the World Cancer Research Fund International (WCRFI), in 2020, France had the highest prevalence of prostate cancer as about 138,100 people were suffering from the disease.

Furthermore, the transrectal ultrasound market has gained maturity in the developed regions; however, the market is expected to grow owing to increase in demand of handheld ultrasound devices.

In addition, growing demand for high quality images that provide reliable measurement and diagnostic confidence boosts the transrectal ultrasound market growth. Moreover, high-resolution ultrasound scanning and real-time diagnosis of prostate cancer are driving the shift of diagnostic approaches of urological disorders and prostate cancer from conventional methods to advanced techniques.

Furthermore, increase in prevalence of benign prostatic hyperplasia and rise in healthcare facilities in developing countries such as India, China, and Japan are some transrectal ultrasound market trends expected to create new opportunities for the market growth during transrectal ultrasound market forecast. For instance, according to Urology Care Foundation (UCF), in 2020, about half of all men between ages 51 and 60 have benign prostatic hyperplasia.

Conversely, dearth of skilled and experienced sonographers, high price of sophisticated ultrasound devices, and unfavorable reimbursement for ultrasound procedures are the major factors restraining the market growth.

COVID-19 is an acute disease in humans caused by a coronavirus, which is characterized mainly by fever and cough and is capable of progressing to severe symptoms and in some cases death, especially in older people and those with underlying health conditions. The COVID-19 pandemic has resulted in a significant decline in demand for transrectal ultrasound across the healthcare sector and negatively impacted the transrectal ultrasound industry.

Furthermore, patients getting screening tests from hospitals were at risk of infection. This is the major factor for slowed market growth of transrectal ultrasound. However, the market is expected to witness recovery in the forecast period, and show stable growth for transrectal ultrasound in the coming future.

On the basis of products, the market is segmented into system and transducer. The system segment dominated the market in 2021, and is expected to exhibit the fastest growth, with a CAGR of 4.4% during the forecast period, owing to increase in adoption of transrectal ultrasound system for diagnosis of rectal abnormalities.

Depending on type, the market is bifurcated into trolley/cart-based and handheld/portable. The trolley/cart-based segment dominated the transrectal ultrasound market share in 2021, owing to more accurate diagnostic capabilities of these devices.

However, the handheld/portable segment is expected to exhibit the fastest growth, with CAGR of 4.9% during the forecast period, owing to rise in demand for handheld ultrasound devices due to the shifting trend of remote patient monitoring. In addition, it provides superior quality of images which is the primary factor for increase in demand for handheld/portable devices.

As per end user, the market is divided into hospitals (public and private), diagnostic laboratories, and others. The diagnostic laboratories segment dominated the market in 2021, owing to increase in number of diagnostic laboratories and rise in number of patients undergoing diagnosis for prostate cancer in these laboratories.

However, the hospitals segment is expected to exhibit the fastest growth, with CAGR of 4.9% during the forecast period, owing to increase in adoption of ultrasound imaging systems in hospital facilities.

Region wise, North America has the highest transrectal ultrasound market share and is expected to remain dominant during the forecast period. North America is leading the market due to adoption of advanced transrectal ultrasound devices in all healthcare systems and strong presence of key players in this region.

However, Asia-Pacific is expected to grow at a fastest rate during the transrectal ultrasound market analysis, owing to rapidly developing hospital infrastructure and rise in healthcare spending in countries such as Japan, China, and India.

KEY FINDINGS OF THE STUDY 
• By product, the system segment was highest contributor to the transrectal ultrasound industry in 2021.
• On the basis of type, the trolley/cart-based segment dominated the market in 2021.
• Based on end user, diagnostic laboratories segment dominated the market in 2021.
• Based on region, North America dominated the market in 2021, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.